Can-Fite BioPharma Ltd.
CANF
$3.39
$0.030.89%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -1.56% | 0.00% | -24.29% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -95.65% | 0.00% | 283.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -68.94% | 0.00% | 142.11% | 0.00% |
| Change in Net Operating Assets | 0.00% | 395.93% | 0.00% | -220.77% | 0.00% |
| Cash from Operations | 0.00% | 11.68% | 0.00% | -31.96% | 0.00% |
| Capital Expenditure | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -200.00% | 0.00% | 200.00% | 0.00% |
| Cash from Investing | 0.00% | -200.07% | 0.00% | 199.93% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 85.92% | 0.00% | -53.30% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Financing | 0.00% | 85.92% | 0.00% | -49.74% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -88.89% | 0.00% | 400.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -156.84% | 0.00% | 1,436.79% | 0.00% |